pharma · Chronic Spontaneous Urticaria · Asthma
Novartis India
Novartis Pharmaceuticals
Novartis India clinical programs — 121 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Founded
- 1996
- Employees
- 2,240
- Programs
- 341
- Drugs
- 317
- Patents
- 0
Novartis India projects
121 ClinicalTrials.gov programs sponsored by Novartis India.
Novartis India has 121 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
LDE225 0.75%
Novartis Pharmaceuticals
Sporadic Superficial and Nodular Skin Basal Cell Carcinomas
1 trial -
LIK066
Novartis Pharmaceuticals
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
1 trial -
LNA043
Novartis Pharmaceuticals
Osteoarthritis
1 trial -
MAS825, -
Novartis Pharmaceuticals
Still’s disease
1 trial -
Midostaurin
Novartis Pharmaceuticals
Acute Myeloid Leukemia
1 trial -
Nilotinib followed by treatment-free
Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
1 trial -
Osilodrostat
Novartis Pharmaceuticals
Cushing's Syndrome
1 trial -
PHE885
Novartis Pharmaceuticals
Multiple Myeloma
1 trial -
PPY988A
Novartis Pharmaceuticals
Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the previous studies GT005-01 (FOCUS), GT005-02 (EXPLORE) and GT005-03 (HORIZON).
1 trial -
Panobinostat
Novartis Pharmaceuticals
Classical Hodgkin's Lymphoma
1 trial -
Patupilone
Novartis Pharmaceuticals
Hepatocellular Carcinoma
1 trial -
QBW251
Novartis Pharmaceuticals
Pulmonary Disease, Chronic Obstructive
1 trial -
Rapcabtagene autoleucel
Novartis Pharmaceuticals
ANCA Associated Vasculitis (AAV)
1 trial -
SODIUM CHLORIDE , DII235
Novartis Pharmaceuticals
Cardiovascular risk reduction in participants with elevated Lp(a)
1 trial -
Scemblix 40 mg film-coated tablets
Novartis Pharmaceuticals
CML-CP or CML-AP patients with T315I mutation
1 trial -
Seasonal flu vaccine
Novartis Pharmaceuticals
Seasonal Influenza
1 trial -
Serelaxin
Novartis Pharmaceuticals
Acute Heart Failure
1 trial -
TISAGENLECLEUCEL
Novartis Pharmaceuticals
High-risk B-cell acute lymphoblastic leukemia
1 trial -
TISAGENLECLEUCEL
Novartis Pharmaceuticals
Adult patients with refractory or relapsed follicular lymphoma
1 trial -
Vi-CRM197 vaccine
Novartis Pharmaceuticals
Typhoid Fever
1 trial -
alb-interferon alfa 2b
Novartis Pharmaceuticals
Chronic Hepatitis C
1 trial -
cyclosporine (reduced exposure) / everolimus
Novartis Pharmaceuticals
Kidney Transplantation
1 trial -
eltrombopag
Novartis Pharmaceuticals
Thrombocytopaenia
1 trial -
rapcabtagene autoleucel
Novartis Pharmaceuticals
Scleroderma, Diffuse
1 trial -
zigakibart
Novartis Pharmaceuticals
Immunoglobulin A Nephropathy (IgAN)
1 trial
Frequently asked questions
How many clinical projects does Novartis India have?
121 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.